Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-23
1991-01-22
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
049871501
ABSTRACT:
An agent for inhibiting the binding of 5.alpha.-dihydrotestosterone with androgen receptor, which comprises at least one extract from herbs or one of specific xanthone compounds, and a process for obtaining the agent.
REFERENCES:
patent: 3133864 (1964-05-01), Hagiwara
Komatsu et al., "Studies on the Constituents of Swertia japonica. IV. Isolation and Structure of Xanthones", Chem. Pharm. Bull., 17(1) 155-162 (1969).
Ghosal et al., "Chemical Constituents of the Gentianaceae V: Tetraoxygenated Xanthones of Swertia chirata Buch.-Ham." J. Pharm. Sci., 62(6) 926-930 (1973).
Conn's Current Therapy, 1984, pp. 599-603.
Current Therapy, 1981, p. 662.
Iida Takafumi
Kato Eiichi
Koshizaka Takuya
Kurono Masayasu
Ohishi Nobuko
Kabushiki Kaisha Vitamin Kenkyusho
Rollins John W.
LandOfFree
Agent for inhibiting binding of 5-dihydro-testosterone with andr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for inhibiting binding of 5-dihydro-testosterone with andr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for inhibiting binding of 5-dihydro-testosterone with andr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555093